Germline mutations in RUNX1 cause autosomal dominant Familial Platelet Disorder (FPD), with a propensity to evolve into myeloid malignancy (FPD-MM), i.e., MDS or AML [1–3, 5, 6]. Here, RUNX1 is linked to myelodysplastic syndrome.